HUTCHMED (China) (HCM) Change in Accured Expenses (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Change in Accured Expenses came in at $221.1 million in Q2 2025, down 11.3% year-on-year from $249.2 million in Q2 2024, and down 99.33% on a QoQ basis from $32.9 billion in Q4 2024.

HUTCHMED (China) (HCM) Change in Accured Expenses (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 11 years of Change in Accured Expenses data on file, last reported at $221.1 million in Q2 2025.

  • On a quarterly basis, Change in Accured Expenses fell 11.3% year-over-year to $221.1 million in Q2 2025; TTM through Jun 2025 was $221.1 million, a 11.3% decrease from a year earlier, with the FY2025 full-year figure at -$48.6 million, down 2095.52% from the prior year.
  • Change in Accured Expenses for Q2 2025 stood at $221.1 million, down from $32.9 billion in the prior quarter.
  • Over the last five years, Change in Accured Expenses for HCM reached as high as $34.7 billion in Q4 2023 and fell as low as $27.1 million in Q4 2021.
  • Historically, Change in Accured Expenses has averaged $6.9 billion across 5 years, with a median of $224.1 million in 2023.
  • Across the five-year window, Change in Accured Expenses soared 102575.61% in 2023 and slipped 11.3% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $27.1 million in 2021, then advanced by 24.98% to $33.8 million in 2022, then surged by 102575.61% to $34.7 billion in 2023, then fell by 5.15% to $32.9 billion in 2024, then tumbled by 99.33% to $221.1 million in 2025.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were $221.1 million in Q2 2025, $32.9 billion in Q4 2024, and $249.2 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 HUTCHMED (China) 9.55 Bn 9.38 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 221.06 Mn
Jun 30, 2025 221.06 Mn
Dec 31, 2024 32.95 Bn
Dec 31, 2024 32.95 Bn
Jun 30, 2024 249.22 Mn
Jun 30, 2024 249.22 Mn
Dec 31, 2023 34.73 Bn
Dec 31, 2023 34.73 Bn
Jun 30, 2023 227.21 Mn
Jun 30, 2023 227.21 Mn
Dec 31, 2022 33.83 Mn
Dec 31, 2022 33.83 Mn
Jun 30, 2022 233.61 Mn
Jun 30, 2022 233.61 Mn
Dec 31, 2021 27.07 Mn
Dec 31, 2021 27.07 Mn
Jun 30, 2021 181.61 Mn
Jun 30, 2021 181.61 Mn
Mar 31, 2021 150.33 Mn
Mar 31, 2021 150.33 Mn